Your browser doesn't support javascript.
loading
Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience.
Dholaria, Bhagirathbhai; Mehraban, Nasima; Baer, Brittney; Long, Nancy; Jayani, Reena V; Byrne, Michael T; Kassim, Adetola A; Engelhardt, Brian G; Savani, Bipin N; Oluwole, Olalekan O.
Afiliação
  • Dholaria B; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Mehraban N; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Baer B; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Long N; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Jayani RV; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Byrne MT; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Kassim AA; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Engelhardt BG; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Savani BN; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Oluwole OO; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Br J Haematol ; 198(6): 1073-1075, 2022 09.
Article em En | MEDLINE | ID: mdl-35765247

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Telemedicina Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Telemedicina Idioma: En Ano de publicação: 2022 Tipo de documento: Article